Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas
Cancer, 04/25/2012
Mullen JT et al. – For patients with high–risk, extremity soft tissue sarcomas (STS), the significant survival benefits conferred by an intense regimen of neoadjuvant chemoradiotherapy and surgery are sustained even with long–term follow–up.



